US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 19.950
  • +0.840+4.40%
Close Feb 14 16:00 ET
  • 19.950
  • 0.0000.00%
Post 20:01 ET
2.52BMarket Cap-3.87P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-24.13%-146.27M
-200.77%-462.85M
-429.26%-137.22M
-455.51%-115.42M
-191.68%-92.38M
-56.05%-117.84M
-13.05%-153.89M
62.28%-25.93M
69.81%-20.78M
-150.49%-31.67M
Net income from continuing operations
-29.43%-175.22M
-191.34%-609.69M
-56.14%-173.34M
-67.08%-173.98M
-366.37%-127M
-223.78%-135.38M
-18.57%-209.28M
-29.17%-111.02M
-44.53%-104.13M
7.46%47.68M
Operating gains losses
----
--80K
--160K
--0
--0
---80K
----
----
----
----
Depreciation and amortization
22.80%5.24M
48.84%18.6M
30.22%5.03M
45.97%4.78M
69.54%4.53M
58.53%4.26M
19.88%12.49M
45.08%3.86M
26.29%3.28M
2.89%2.67M
Other non cash items
303.32%21.65M
76.54%32.35M
178.35%14.65M
-1.26%5.09M
43.27%7.25M
88.38%5.37M
--18.33M
--5.26M
206.29%5.16M
730.38%5.06M
Change In working capital
31.57%-7.44M
148.68%25.09M
-86.47%7.95M
-55.93%24.64M
103.15%3.37M
81.67%-10.87M
47.56%-51.55M
513.17%58.77M
239.12%55.92M
-473.48%-106.91M
-Change in receivables
---2.5M
--0
--0
--0
--0
--0
-84.06%1.41M
206.40%1.25M
6,225.42%68.19M
-2,459.30%-29.87M
-Change in prepaid assets
66.13%-592K
-114.34%-1.66M
100.50%82K
-88.20%897K
-109.15%-895K
-116.60%-1.75M
160.15%11.6M
-56.47%-16.31M
236.91%7.6M
441.60%9.78M
-Change in payables and accrued expense
61.66%-4.62M
47.40%26.58M
-76.26%10.71M
474.18%24.28M
132.18%3.64M
-29.97%-12.06M
61.57%18.03M
246.74%45.11M
3.06%-6.49M
-190.35%-11.32M
-Change in other current liabilities
-129.72%-1.13M
----
----
----
----
579.07%3.8M
----
----
----
----
-Change in other working capital
261.89%1.4M
100.21%174K
-96.60%1.04M
70.97%-4.42M
105.89%4.42M
96.23%-866K
16.58%-82.59M
295.33%30.55M
46.51%-15.21M
-172.68%-74.95M
Cash from discontinued investing activities
Operating cash flow
-24.13%-146.27M
-200.77%-462.85M
-429.26%-137.22M
-455.51%-115.42M
-191.68%-92.38M
-56.05%-117.84M
-13.05%-153.89M
62.28%-25.93M
69.81%-20.78M
-150.49%-31.67M
Investing cash flow
Cash flow from continuing investing activities
18.62%76.91M
-336.87%-420.07M
-830.68%-222.92M
170.16%6.95M
-645.70%-268.94M
180.35%64.84M
-1,675.06%-96.16M
-16.29%30.51M
-116.16%-9.91M
48.30%-36.07M
Net PPE purchase and sale
89.05%-7.52M
19.96%-141.47M
61.99%-24.29M
69.00%-14.45M
-24.75%-34.08M
-76.44%-68.66M
-234.88%-176.74M
-95.37%-63.91M
-388.73%-46.61M
-474.79%-27.31M
Net investment purchase and sale
-36.76%84.43M
-445.74%-278.6M
-310.38%-198.63M
-41.69%21.4M
-2,583.83%-234.86M
419.50%133.5M
70.15%80.58M
36.53%94.42M
-48.17%36.7M
86.54%-8.75M
Cash from discontinued investing activities
Investing cash flow
18.62%76.91M
-336.87%-420.07M
-830.68%-222.92M
170.16%6.95M
-645.70%-268.94M
180.35%64.84M
-1,675.06%-96.16M
-16.29%30.51M
-116.16%-9.91M
48.30%-36.07M
Financing cash flow
Cash flow from continuing financing activities
7,628.09%20.63M
244.01%870.52M
47,292.08%389.09M
4,335.48%50.39M
82,741.73%430.78M
-99.89%267K
288.20%253.05M
-3.98%821K
-98.13%1.14M
-71.83%520K
Net issuance payments of debt
----
--392M
----
----
----
----
--0
----
----
----
Net common stock issuance
----
--429.27M
--0
--0
----
----
--0
--0
--0
----
Proceeds from stock option exercised by employees
9,500.75%25.63M
-21.75%2.39M
-72.84%223K
-65.93%387K
190.77%1.51M
-53.65%267K
-41.13%3.05M
-3.98%821K
89.33%1.14M
-71.83%520K
Net other financing activities
---5M
-81.25%46.87M
---3.13M
----
----
----
316.67%250M
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
7,628.09%20.63M
244.01%870.52M
47,292.08%389.09M
4,335.48%50.39M
82,741.73%430.78M
-99.89%267K
288.20%253.05M
-3.98%821K
-98.13%1.14M
-71.83%520K
Net cash flow
Beginning cash position
-7.40%102.69M
2.67%110.89M
-34.12%69.4M
-5.38%127.7M
-71.22%58.22M
2.67%110.89M
-41.44%108.01M
-24.46%105.33M
56.19%134.96M
120.83%202.25M
Current changes in cash
7.60%-48.73M
-512.33%-12.4M
435.71%28.95M
-96.58%-58.08M
203.34%69.46M
-155.88%-52.73M
103.94%3.01M
117.19%5.4M
-155.68%-29.55M
-1,197.61%-67.22M
Effect of exchange rate changes
-217.24%-68K
3,540.16%4.2M
2,733.99%4.34M
-182.28%-223K
135.14%26K
147.54%58K
-82.09%-122K
5,000.00%153K
-146.88%-79K
-7,500.00%-74K
End cash Position
-7.43%53.89M
-7.40%102.69M
-7.40%102.69M
-34.12%69.4M
-5.38%127.7M
-71.22%58.22M
2.67%110.89M
2.67%110.89M
-24.46%105.33M
56.19%134.96M
Free cash flow
17.54%-153.79M
-82.78%-604.32M
-79.78%-161.51M
-92.73%-129.87M
-114.38%-126.45M
-62.98%-186.5M
-75.02%-330.63M
11.45%-89.83M
14.00%-67.38M
-201.74%-58.99M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -24.13%-146.27M-200.77%-462.85M-429.26%-137.22M-455.51%-115.42M-191.68%-92.38M-56.05%-117.84M-13.05%-153.89M62.28%-25.93M69.81%-20.78M-150.49%-31.67M
Net income from continuing operations -29.43%-175.22M-191.34%-609.69M-56.14%-173.34M-67.08%-173.98M-366.37%-127M-223.78%-135.38M-18.57%-209.28M-29.17%-111.02M-44.53%-104.13M7.46%47.68M
Operating gains losses ------80K--160K--0--0---80K----------------
Depreciation and amortization 22.80%5.24M48.84%18.6M30.22%5.03M45.97%4.78M69.54%4.53M58.53%4.26M19.88%12.49M45.08%3.86M26.29%3.28M2.89%2.67M
Other non cash items 303.32%21.65M76.54%32.35M178.35%14.65M-1.26%5.09M43.27%7.25M88.38%5.37M--18.33M--5.26M206.29%5.16M730.38%5.06M
Change In working capital 31.57%-7.44M148.68%25.09M-86.47%7.95M-55.93%24.64M103.15%3.37M81.67%-10.87M47.56%-51.55M513.17%58.77M239.12%55.92M-473.48%-106.91M
-Change in receivables ---2.5M--0--0--0--0--0-84.06%1.41M206.40%1.25M6,225.42%68.19M-2,459.30%-29.87M
-Change in prepaid assets 66.13%-592K-114.34%-1.66M100.50%82K-88.20%897K-109.15%-895K-116.60%-1.75M160.15%11.6M-56.47%-16.31M236.91%7.6M441.60%9.78M
-Change in payables and accrued expense 61.66%-4.62M47.40%26.58M-76.26%10.71M474.18%24.28M132.18%3.64M-29.97%-12.06M61.57%18.03M246.74%45.11M3.06%-6.49M-190.35%-11.32M
-Change in other current liabilities -129.72%-1.13M----------------579.07%3.8M----------------
-Change in other working capital 261.89%1.4M100.21%174K-96.60%1.04M70.97%-4.42M105.89%4.42M96.23%-866K16.58%-82.59M295.33%30.55M46.51%-15.21M-172.68%-74.95M
Cash from discontinued investing activities
Operating cash flow -24.13%-146.27M-200.77%-462.85M-429.26%-137.22M-455.51%-115.42M-191.68%-92.38M-56.05%-117.84M-13.05%-153.89M62.28%-25.93M69.81%-20.78M-150.49%-31.67M
Investing cash flow
Cash flow from continuing investing activities 18.62%76.91M-336.87%-420.07M-830.68%-222.92M170.16%6.95M-645.70%-268.94M180.35%64.84M-1,675.06%-96.16M-16.29%30.51M-116.16%-9.91M48.30%-36.07M
Net PPE purchase and sale 89.05%-7.52M19.96%-141.47M61.99%-24.29M69.00%-14.45M-24.75%-34.08M-76.44%-68.66M-234.88%-176.74M-95.37%-63.91M-388.73%-46.61M-474.79%-27.31M
Net investment purchase and sale -36.76%84.43M-445.74%-278.6M-310.38%-198.63M-41.69%21.4M-2,583.83%-234.86M419.50%133.5M70.15%80.58M36.53%94.42M-48.17%36.7M86.54%-8.75M
Cash from discontinued investing activities
Investing cash flow 18.62%76.91M-336.87%-420.07M-830.68%-222.92M170.16%6.95M-645.70%-268.94M180.35%64.84M-1,675.06%-96.16M-16.29%30.51M-116.16%-9.91M48.30%-36.07M
Financing cash flow
Cash flow from continuing financing activities 7,628.09%20.63M244.01%870.52M47,292.08%389.09M4,335.48%50.39M82,741.73%430.78M-99.89%267K288.20%253.05M-3.98%821K-98.13%1.14M-71.83%520K
Net issuance payments of debt ------392M------------------0------------
Net common stock issuance ------429.27M--0--0----------0--0--0----
Proceeds from stock option exercised by employees 9,500.75%25.63M-21.75%2.39M-72.84%223K-65.93%387K190.77%1.51M-53.65%267K-41.13%3.05M-3.98%821K89.33%1.14M-71.83%520K
Net other financing activities ---5M-81.25%46.87M---3.13M------------316.67%250M--0--0--0
Cash from discontinued financing activities
Financing cash flow 7,628.09%20.63M244.01%870.52M47,292.08%389.09M4,335.48%50.39M82,741.73%430.78M-99.89%267K288.20%253.05M-3.98%821K-98.13%1.14M-71.83%520K
Net cash flow
Beginning cash position -7.40%102.69M2.67%110.89M-34.12%69.4M-5.38%127.7M-71.22%58.22M2.67%110.89M-41.44%108.01M-24.46%105.33M56.19%134.96M120.83%202.25M
Current changes in cash 7.60%-48.73M-512.33%-12.4M435.71%28.95M-96.58%-58.08M203.34%69.46M-155.88%-52.73M103.94%3.01M117.19%5.4M-155.68%-29.55M-1,197.61%-67.22M
Effect of exchange rate changes -217.24%-68K3,540.16%4.2M2,733.99%4.34M-182.28%-223K135.14%26K147.54%58K-82.09%-122K5,000.00%153K-146.88%-79K-7,500.00%-74K
End cash Position -7.43%53.89M-7.40%102.69M-7.40%102.69M-34.12%69.4M-5.38%127.7M-71.22%58.22M2.67%110.89M2.67%110.89M-24.46%105.33M56.19%134.96M
Free cash flow 17.54%-153.79M-82.78%-604.32M-79.78%-161.51M-92.73%-129.87M-114.38%-126.45M-62.98%-186.5M-75.02%-330.63M11.45%-89.83M14.00%-67.38M-201.74%-58.99M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
+17.56%
DexCom
DXCM
+5.92%
Hutchmed (China)
HCM
+4.39%
New Fortress Energy
NFE
+2.70%
Enerpac Tool
EPAC
+1.85%

Unlock the Full List